Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma

Figure 5

Relationship between risk score and immune microenvironment. (a) The percentage abundances of different immune cell types in the high-risk subtype and low-risk subtype. (b) The expression of different immune cell types in the high-risk subtype and low-risk subtype. (c) Correlation between the risk score and the levels of different immune cell types.

(a)

(b)

(c)